胃肠道肿瘤合并糖尿病术后早期实施肠内营养支持对控制血糖的有效性和安全性分析

2021-12-13陈剑飞张希广

婚育与健康 2021年21期

陈剑飞张希广

【摘要】目的：探讨胃肠道肿瘤合并糖尿病术后早期实施肠内营养支持对控制血糖的有效性和安全性。方法：选取胃肠道肿瘤合并糖尿病患者100例进行观察研究，分别采取肠外营养支持与肠内营养支持，通过对比两组患者的血糖变化情况、患者的SAS评分、SDS评分及治疗效果进行评判。结果：观察组患者的血糖变化情况优于对照组患者，观察组患者的SAS评分、SDS评分相对较优，观察组患者的治疗效率势态更好，差异显著（P<0.05），有统计学意义。结论：肠内营养支持能够帮助手术后的患者对血糖进行控制，减少患者的并发症发生率，促进患者的康复。

【关键词】胃肠道肿瘤；糖尿病；术后恢复；肠内营养支持

Analysis of the effectiveness and safety of early enteral nutrition support for blood glucose control in patients with gastrointestinal tumors combined with diabetes

Chen Jianfei1， Zhang Xiguang2

1 Department of General Surgery， Shandong Dezhou United Hospital， Shandong Dezhou，253000， China；2.Surgery， PingyuanXincheng Hospital， Dezhoucity， Shandongprovince，Shandong Dezhou，253000， China

【Abstract】Objective： To investigate the effectiveness and safety of early enteral nutrition support for blood glucose control after gastrointestinal tumors combined with diabetes. Methods： 100 patients with gastrointestinal cancer and diabetes mellitus were selected for observation and study. Parenteral nutrition support and enteral nutrition support were adopted respectively. The blood glucose changes， SAS scores， SDS scores and therapeutic effects of the two groups were compared. Results： The blood glucose changes of the observation group were better than those of the control group. The SAS score and SDS score of the observation group were relatively better. The treatment efficiency of the observation group was better. The difference was significant （p<0.05） and statistical significance. Conclusion： Enteral nutrition support can help patients control blood sugar after surgery， reduce the incidence of complications， and promote the recovery of patients.

【Key？Words】Gastrointestinal tumors； Diabetes； Postoperative recovery； Enteral nutrition support

糖尿病是臨床上常见且高发的疾病，目前我国糖尿病患病人数为世界第一，需要长时间的控制治疗[1]。通常胃肠道肿瘤合并糖尿病患者在手术过程中会引起血糖的异常增高。本文就胃肠道肿瘤合并糖尿病术后早期实施肠内营养支持对控制血糖的有效性和安全性进行探讨，现报道如下。